|
Powered by Cell Signaling Technology |
Site Information |
---|
CADVPLLtPSsKEMM SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 447950 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Regulatory protein: | |
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on Ets-1: | |
Effects of modification on biological processes: | |
Induce interaction with: |
References | |
---|---|
Piserchio A, et al. (2017) Local destabilization, rigid body, and fuzzy docking facilitate the phosphorylation of the transcription factor Ets-1 by the mitogen-activated protein kinase ERK2. Proc Natl Acad Sci U S A 114, E6287-E6296
28716922 Curated Info |
|
Nelson ML, et al. (2010) Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP. Proc Natl Acad Sci U S A 107, 10026-31
20534573 Curated Info |
|
Yasuda T, et al. (2008) Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity 28, 499-508
18356083 Curated Info |
|
Moisan J, et al. (2007) Ets-1 is a negative regulator of Th17 differentiation. J Exp Med 204, 2825-35
17967903 Curated Info |
|
Paumelle R, et al. (2002) Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 21, 2309-19
11948414 Curated Info |